New Study Reveals Serious Long-Term Complications in Youth-Onset Type 2 Diabetes

The TODAY study team at the CCTSI's Clinical and Translational Research Center

Findings from a new study published in the New England Journal of Medicine underscore the importance of early, intensive treatment for youth-onset type 2 diabetes.

Phil Zeitler, MD, PhD, has been treating youth with type 2 diabetes for more than 20 years. He and a team of researchers published a paper today on the TODAY2 study in the New England Journal of Medicine on the long-term complications of type 2 diabetes. (TODAY stands for Treatment Options for type 2 Diabetes in Adolescents and Youth. The first phase of the study took place from 2004 - 2011; phase two from 2011 - 2020. Both studies involved more than 550 participants from across the country.)

Zeitler is the chair of the TODAY study group and is a professor of pediatrics, endocrinology at the University of Colorado School of Medicine and medical director of the pediatric Clinical and Translational Research Center at Children’s Hospital Colorado, both located on the University of Colorado Anschutz Medical Campus.

CTSA Program In Action Goals
Goal 3: Promote the Integration of Special and Underserved Populations in Translational Research Across the Human Lifespan